On Thursday, Pacira Pharmaceuticals Inc (NASDAQ:PCRX)’s shares declined -16.61% to $68.48.
Pacira Pharmaceuticals Inc (PCRX) offered updates on EXPAREL® (bupivacaine liposome injectable suspension) for postsurgical pain in the United States and declared merged financial results for the first quarter ended March 31, 2015.
Recent Developments
Complete Response Letter: In March, Pacira declared receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following a review of its supplemental New Drug Application (sNDA) for the use of EXPAREL in nerve block to provide postsurgical analgesia.
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States.
Advaxis, Inc. (NASDAQ:ADXS)’s shares dropped -15.49% to $16.81.
Advaxis, Inc. (ADXS) stated revenues for the first quarter of 2015 of $382 million, an enhance of 6% contrast to the preceding year period. Impacts from the strengthening of the US dollar reduced stated revenue growth by 6%. Normalized organic revenue growth1,2 for the quarter was 11.4%, supported by solid growth across business segments. Earnings per diluted share (“EPS”) was $0.98 for the quarter, an enhance of 10% contrast to the preceding year period despite a negative 8% growth impact related to changes in net foreign exchange rates.
IDEXX Laboratories, Inc., together with its auxiliaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
At the end of Thursday’s trade, FormFactor, Inc. (NASDAQ:FORM)‘s shares dipped -13.46% to $7.97.
FormFactor, Inc. (FORM) declared its financial results for the first quarter of fiscal 2015 that ended on March 28, 2015. Quarterly revenues were $70.8 million, down 1% from $71.3 million in the fourth quarter of fiscal 2014, and up 27% from $56.0 million in the first quarter of fiscal 2014.
On a GAAP basis, net income for the first quarter of fiscal 2015 was $0.8 million, or $0.01 per fully-diluted share, contrast to a net loss for the fourth quarter of fiscal 2014 of $(1.9) million, or $(0.03) per fully-diluted share, and a net loss for the first quarter of fiscal 2014 of $(12.7) million, or $(0.23) per fully-diluted share.
FormFactor, Inc. designs, develops, manufactures, sells, and supports semiconductor probe card products and solutions worldwide. The company’s probe cards are used to perform wafer test, which is the testing of the semiconductor die or chips on the semiconductor wafer. ‘
STMicroelectronics NV (ADR) (NYSE:STM), ended its Thursday’s trading session with -13.29% loss, and closed at $7.96.
STMicroelectronics NV (ADR) (STM) stated financial results for the first quarter ended March 28, 2015.
First quarter net revenues totaled $1.71 billion, gross margin was 33.2%, and net loss was $0.03 per share.
ST President and CEO Carlo Bozotti stated that As predictable, the start of the year reflected seasonal softness. Additionally, revenues in the first quarter were affected by the anticipated currency impact on the portion of their euro-denominated revenues, and by lower sales of components for PC applications, both particularly affecting their SP&A segment revenue performance.
STMicroelectronics N.V. designs, develops, manufactures, and markets various semiconductor integrated circuits and discrete devices worldwide. The company offers a range of semiconductor products, counting discrete and standard commodity components, application-specific integrated circuits, full-custom devices and semi-custom devices, micro-electro-mechanical systems, microcontrollers, sensors, digital consumer products, imaging products, memory products, media application processors, and application-specific standard products for analog, digital, and mixed-signal applications, in addition to silicon chips and smartcards.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
